Ketogenesis and Ketosis

Ketogenesis and Ketosis

Overview

  • Ketogenesis and ketosis can occur in any animal species, but ruminants are more prone due to their reliance on gluconeogenesis.

  • Fat mobilization and the rise in ketone bodies is a common physiological response to energy deficiency or increased energy demand.

Ketosis: a metabolic state characterized by elevated levels of ketone bodies in the blood, typically resulting from prolonged fasting, low carbohydrate intake, or strenuous exercise.

Ketogenesis: the biochemical process by which fatty acids are converted into ketone bodies in the liver, serving as an alternative energy source, especially during periods of low glucose availability.

Mechanisms of Ketogenesis

  • Lipolysis and Ketone Body Production:

    • A high rate of lipolysis leads to an increased concentration of non-esterified fatty acids (NEFA) in plasma.

    • This results in an accumulation of acetyl-CoA in hepatocytes (liver cells).

    • For acetyl-CoA to enter the Krebs' cycle, it must condense with oxaloacetate (OAA).

  • Shortage of Carbohydrate Precursors:

    • OAA is derived from carbohydrate (CHO) precursors, which are often in short supply, especially in underfed individuals (human or animal).

    • The result is an increased pool of ketone bodies, including:

    • β-hydroxybutyrate

    • Acetoacetate

    • Acetone

    • Elevated concentrations of ketone bodies can lead to their loss in urine and milk, contributing to energy loss.

Synthesis of Ketone Bodies

  • Ketone bodies are synthesized in the mitochondria of hepatocytes under conditions of excess acetyl-CoA accumulation:

    • Condensation Step:

    • Two molecules of acetyl-CoA are condensed to form acetoacetyl-CoA.

    • Acetoacetyl-CoA then condenses with another acetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA).

    • Cleavage Step:

    • HMG-CoA is cleaved to form acetoacetate and acetyl-CoA.

    • Interconversion:

    • Acetoacetate and β-hydroxybutyrate are interconvertible, with acetoacetate capable of spontaneous decarboxylation to produce acetone.

    • Typically, β-hydroxybutyrate is the major circulating ketone body produced during active ketogenesis.

Utilization of Ketone Bodies by Extrahepatic Tissues

  • Conversion Process:

    • β-hydroxybutyrate is converted back to acetoacetate.

    • Acetoacetate is then converted to acetoacetyl-CoA by the enzyme acetoacetate:succinyl-CoA transferase (also known as β-ketoacyl-CoA-transferase).

  • Tissue Specificity:

    • This enzyme is present in all tissues except the liver, which allows the liver to produce ketone bodies but not utilize them.

    • This mechanism ensures that extrahepatic tissues (e.g., skeletal muscle and heart) have access to ketones as an energy source during prolonged fasting or starvation.

    • Acetyl-CoA generated from ketone bodies is then oxidized in the Krebs' cycle for energy.

Physiological and Clinical Relevance of Ketosis

General Effects

  • Ketosis supports various physiological functions, including:

    • Growth

    • Muscle activity

    • Tissue turnover

    • Immune function

  • In conditions of low glucose availability (e.g., Atkins diet), levels of β-hydroxybutyrate (BHBA) and acetoacetate (AcAc) significantly rise.

Clinical Implications

  • Normal Feeding States:

    • Ketone body production occurs at a low rate under normal feeding conditions and physiological states.

    • Increased production of ketone bodies from acetyl-CoA is a response to carbohydrate shortages, allowing for energy utilization by heart and skeletal muscles while preserving glucose for the brain's use.

  • Diabetic Ketoacidosis (DKA):

    • DKA typically arises from untreated insulin-dependent diabetes mellitus, resulting from a significant reduction in circulating insulin and an increase in glucagon.

    • This leads to an increased fatty acid oxidation and production of acetyl-CoA, which subsequently results in increased ketone body production that exceeds the peripheral tissues' capacity to oxidize them.

    • The accumulation of ketone bodies (which are strong acids, pKa around 3.5) leads to a decrease in blood pH, which can result in acidosis.

  • Pregnancy Toxemia in Ewes:

    • A condition that occurs in sheep during late gestation due to inadequate nutrition, often from inadequate energy density in rations and decreased rumen capacity due to fetal growth.

    • Each fetus requires approximately 30-40 g of glucose per day, leading to significant glucose demand that can direct glucose production away from the ewe, causing increased fat mobilization and potential ketosis as the liver's capacity is overwhelmed.

  • Ketosis in Dairy Cows:

    • Particularly prevalent in early lactation cows experiencing intense adipose mobilization and high glucose demands.

    • High NEFA concentrations (above 0.400 mEq/L) in cows close to calving (2–14 days pre-calving) indicate severe negative energy balance, greatly increasing the risk (2.3 times) of postpartum metabolic diseases, especially ketosis and displaced abomasum.

Regulation of Ketogenesis

  • Ketogenesis is regulated at various levels, including:

    • Adipose lipolysis (to supply substrate)

    • β-oxidation (to produce acetyl-CoA)

    • Short- and long-term regulation of hepatic enzymes involved in ketogenesis.

Ketone Level Ranges (Blood Beta-Hydroxybutyrate Ranges)

  • 0.0 – 0.4 mmol/L: No ketosis.

  • 0.5 – 1.0 mmol/L: Light nutritional ketosis (initial stage).

  • 1.0 – 3.0 mmol/L: Optimal nutritional ketosis (ideal for fat loss).

  • 3.0 – 5.0 mmol/L: High/therapeutic ketosis.

  • > 5.0 mmol/L: High levels, usually resulting from fasting or extreme diets.

  • > 8.0 mmol/L: Danger zone indicating ketoacidosis risk.